To validate the presence of TERT promoter mutations in a separate cohort, we queried the NCI TARGET data for Wilms tumors that underwent whole genome sequencing and found that 3/81 (3.7%) contained the C228T TERT promoter mutation (Data File S1) [7]. The gene discussed is TERT; the disease is Nephroblastoma.